Skip to Content

IDEXX Laboratories Inc IDXX Stock Quote

| Rating as of


Market Closed

| Currency in USD

  • Last Close 430.95
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Investment Style Mid Growth
  • Day Range 425.51  –  435.00
  • Year Range 317.06  –  564.74
  • Market Cap 35.7742 Bil
  • Volume / Avg 413,082.0 /  452,786.1
  • Price / Sales 10.30
  • Price / Book 32.89
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis IDXX

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Idexx Flexes Its Pricing Muscle, but Longer-Term Impact on Demand Is Unclear

Debbie S. Wang Senior Equity Analyst

Business Strategy and Outlook

| Debbie Wang |

Idexx Laboratories has steadily increased its scale and reach in the veterinary diagnostic lab business to dig a narrow moat. It is well-positioned to benefit from two key trends. First, pet ownership continues to grow, offering a secular tailwind since the late 1980s. Moreover, pet owners have demonstrated greater willingness to spend more on their animals, having more than tripled spending on pet products and services since 1994.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics IDXX

Company Profile IDXX

Business Description

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.

One IDEXX Drive
Westbrook, ME, 04092
Industry Diagnostics & Research
Employees 10,780

Related Articles IDXX

Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of IDXX’s competitive advantage.

IDEXX Laboratories Inc


Zoetis Inc Class A

−$6.32 (1.45%) −$1.25 (0.72%)
Market Cap
35.77 Bil79.51 Bil
Diagnostics & Research Drug Manufacturers - Specialty & Generic

* Trading data in this section is delayed by at least 15 minutes.

FAQs for IDEXX Laboratories Inc Stock

No. IDXX does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

IDXX’s market cap is 35.77 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

IDXX’s stock style is Mid Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

IDXX’s price/sales is 10.30.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

IDXX’s price/forward earnings is 45.70.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

IDXX’s price/book is 32.89.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See IDXX’s valuation ratios compared to the Market Index.

IDXX’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare IDXX’s historical performance against its industry peers and the overall market.